- Home
- FLC vs SENS Comparison
FLC vs SENS Comparison
Compare FLC & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLC
- SENS
- Stock Information
- Founded
- FLC 2003
- SENS 1996
- Country
- FLC United States
- SENS United States
- Employees
- FLC N/A
- SENS N/A
- Industry
- FLC Trusts Except Educational Religious and Charitable
- SENS Industrial Machinery/Components
- Sector
- FLC Finance
- SENS Industrials
- Exchange
- FLC Nasdaq
- SENS Nasdaq
- Market Cap
- FLC 176.2M
- SENS 179.7M
- IPO Year
- FLC N/A
- SENS N/A
- Fundamental
- Price
- FLC $17.04
- SENS $0.91
- Analyst Decision
- FLC
- SENS Strong Buy
- Analyst Count
- FLC 0
- SENS 1
- Target Price
- FLC N/A
- SENS $2.00
- AVG Volume (30 Days)
- FLC 37.8K
- SENS 18.6M
- Earning Date
- FLC 01-01-0001
- SENS 02-27-2025
- Dividend Yield
- FLC 6.64%
- SENS N/A
- EPS Growth
- FLC N/A
- SENS N/A
- EPS
- FLC N/A
- SENS N/A
- Revenue
- FLC N/A
- SENS $22,205,000.00
- Revenue This Year
- FLC N/A
- SENS $0.43
- Revenue Next Year
- FLC N/A
- SENS $60.55
- P/E Ratio
- FLC N/A
- SENS N/A
- Revenue Growth
- FLC N/A
- SENS 11.41
- 52 Week Low
- FLC $12.62
- SENS $0.25
- 52 Week High
- FLC $15.45
- SENS $0.93
- Technical
- Relative Strength Index (RSI)
- FLC 62.14
- SENS 73.96
- Support Level
- FLC $16.55
- SENS $0.67
- Resistance Level
- FLC $16.89
- SENS $0.93
- Average True Range (ATR)
- FLC 0.22
- SENS 0.11
- MACD
- FLC 0.03
- SENS 0.03
- Stochastic Oscillator
- FLC 98.44
- SENS 95.12
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.